Oct 18 (Reuters) - CHF Solutions Inc :CHF Solutions Inc files for offering of up to $8.0 million of common stock - SEC filing.
Oct 18 (Reuters) - SUPERSONIC IMAGINE SA ::SUPERSONIC IMAGINE REPORTS SALES GROWTH OF +13% IN Q3 2017 (+16% AT CONSTANT CURRENCY).Q3 REVENUE EUR 6.4 MILLION VERSUS EUR 5.7 MILLION YEAR AGO.3(RD) QUARTER OF 2017, COMPANY GENERATED GROWTH OF +13% TO EUR 6.45 MILLION.OVER FIRST NINE MONTHS OF 2017 SUPERSONIC IMAGINE RECORDED TOTAL REVENUES OF EUR 16.74 MILLION, UP 7%.
Oct 18 (Reuters) - Viveve Medical Inc :Viveve releases preliminary third quarter 2017 financial results.Viveve Medical- sees Q3 revenue from sale of 60 Viveve systems, about 2,700 disposable treatment tips, ancillary consumables to be about $4.1 million.
Oct 17 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::MAUNA KEA TECHNOLOGIES APPOINTS OLIVIER REGNARD AS DEPUTY CEO AND CHIEF FINANCIAL OFFICER.
Oct 17 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Mexico.Viveve Medical - received approval from Mexican regulatory authority, COFEPRIS, to market Viveve System in Mexico for treatment of vaginal introitus.Viveve Medical Inc - working to submit IDE to FDA to conduct pivotal study on use of Viveve System for improvement in sexual function in women.
Oct 17 (Reuters) - THERACLION SA ::RAISES EUR 4.2 MILLION THROUGH PRIVATE PLACEMENT WITH INSTITUTIONAL INVESTORS.ISSUES 989,113 ORDINARY SHARES WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTS FOR INSTITUTIONAL INVESTORS.ISSUES ORDINARY SHARES TO FUND PENDING CLINICAL TRIALS.PRICE OF PRIVATE PLACEMENT WAS SET AT EUR 4.22 PER SHARE.SETTLEMENT-DELIVERY TO TAKE PLACE ON OCT 19, 2017.
Oct 16 (Reuters) - Restoration Robotics Inc :Restoration Robotics Inc. Announces closing of its initial public offering.Says initial public offering of 4.11 million common shares priced at $7.00 per share.
Oct 16 (Reuters) - Sartorius Ag - :9 months business performance of Bioprocess solutions division in 2017 temporary weaker than expected .Key figures on 9-month business development in 2017.Full-year 2017 guidance adjusted.Mid-term outlook and targets remain unchanged.For first nine months of 2017, Sartorius group achieved revenue growth of 8.6% in constant currencies to about 1.04 billion euros.For first nine months of 2017, Sartorius group achieved an underlying EBIDTA margin of 24.8% versus 9 month 2016 25.0%.Sartorius group now expects that sales revenue in constant currencies will increase by approx. 9% for full-year of 2017.Underlying EBIDTA margin in constant currencies now projected to reach approx. Prior-Year level of around 25.0% for FY 2017.
Oct 16 (Reuters) - Tetraphase Pharmaceuticals Inc ::TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER.MOST RECENTLY, KAMALAM UNNINAYAR SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC.KAMALAM UNNINAYAR MOST RECENTLY SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC.
Oct 16 (Reuters) - Analogic Corp :Plans to re-affirm its fiscal 2018 outlook .Q1 revenue is expected to be lower than Q4 of fiscal 2017 - SEC filing.As a result of co's completed restructuring actions, overall profitability is expected to improve in FY 2018 despite expected lower y-o-y revenues.Fy2018 earnings per share view $2.81 -- Thomson Reuters I/B/E/S.Fy2018 revenue view $453.7 million -- Thomson Reuters I/B/E/S.